Point of care microspirometry to facilitate the COPD diagnostic process in primary care: a clustered randomised trial.
Ontology highlight
ABSTRACT: We studied if pre-bronchodilator FEV1/FEV6 determinations with microspirometers by GPs improve the diagnostic process for COPD in a 6-8 month clustered randomised controlled trial in Dutch general practices ( http://www.trialregister.nl : NTR4041). GPs allocated to microspirometry (MI) used COPD-6® microspirometers in patients ≥50 years old with a smoking history and respiratory complaints that could indicate undiagnosed COPD and ask to refer patients for full spirometry if MI was positive (FEV1/FEV6 <0.73). Introduction of the COPD-6® was postponed in the usual care (UC) group. GPs of both study arms were asked to list all patients that fulfilled study criteria and at the end of the study we screened the electronic medical
SUBMITTER: Schermer TR
PROVIDER: S-EPMC5964085 | biostudies-literature | 2018 May
REPOSITORIES: biostudies-literature
ACCESS DATA